Vasospasm: an update.
D000804:Angiotensin II / Q000378:metabolism; D000818:Animals; D001769:Blood; D002533:Cerebral Angiography; D002536:Cerebral Arteries / Q000473:pathology; D003937:Diagnosis, Differential; D004195:Disease Models, Animal; D004298:Dopamine / Q000627:therapeutic use; D004837:Epinephrine / Q000633:toxicity; D006801:Humans; D002532:Intracranial Aneurysm / Q000150:complications; D002546:Ischemic Attack, Transient / Q000175:diagnosis / Q000209:etiology / Q000628:therapy; D009638:Norepinephrine / Q000633:toxicity; D010108:Oxyhemoglobins / Q000378:metabolism; D010812:Physical Stimulation; D011453:Prostaglandins / Q000378:metabolism; D012110:Reserpine / Q000627:therapeutic use; D012701:Serotonin / Q000378:metabolism; D013345:Subarachnoid Hemorrhage / Q000150:complications / Q000473:pathology; D013577:Syndrome
D010108:Oxyhemoglobins; D011453:Prostaglandins; D000804:Angiotensin II; D012701:Serotonin; D012110:Reserpine; D004298:Dopamine; D009638:Norepinephrine; D004837:Epinephrine